Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature-Reference-Cited by-同舟云学术

Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature

Published:2020-01-02 Issue:2 Volume:301 Page:341-353
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Banys-Paluchowski Malgorzata^ORCID,Gruber Ines Verena,Hartkopf Andreas,Paluchowski Peter,Krawczyk Natalia,Marx Mario,Brucker Sara,Hahn Markus

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00404-019-05428-x.pdf

Reference62 articles.

1. de Bellefon M, Lemanski C, Ducteil A, Fenoglietto P, Azria D, Bourgier C (2018) Management of the axilla in the era of breast cancer heterogeneity. Front Oncol 8:84. https://doi.org/10.3389/fonc.2018.00084

2. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318:918–926. https://doi.org/10.1001/jama.2017.11470

3. Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15:1303–1310. https://doi.org/10.1016/S1470-2045(14)70460-7

4. Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35:561–564. https://doi.org/10.1200/JCO.2016.71.0947

5. AGO Breast Committee (2019) Diagnosis and treatment of patients with primary and metastatic breast cancer. Recommendations 2019. www.ago-online.de. Accessed 1 Oct 2019

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomogram Based on US and Clinicopathologic Characteristics: Axillary Nodal Evaluation Following Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer;Clinical Breast Cancer;2024-08

2. Comparing shear wave elastography of breast tumors and axillary nodes in the axillary assessment after neoadjuvant chemotherapy in patients with node-positive breast cancer;La radiologia medica;2024-07-26

3. Brusttumoren;PET/CT-Atlas;2024

4. Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients—a single institution experience;World Journal of Surgical Oncology;2023-09-16

5. Controversies in axillary management of patients with breast cancer – updates for 2024;Current Opinion in Obstetrics & Gynecology;2023-09-07